Tryptamine Therapeutics Concludes Phase 2a Clinical Study for Pain and Tenderness Drug; Shares Rise 11%
Tryptamine Therapeutics Concludes Phase 2a Clinical Study for Pain and Tenderness Drug; Shares Rise 11%
Tryptamine治療已完成疼痛和嫌惡症狀藥物的2a臨床研究；股價上漲11％。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊